Pedro Rocha
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Cancer Genomics and Diagnostics
Papers in
- Oncology 34
- Lung Cancer Research Studies 17
- Cancer Immunotherapy and Biomarkers 12
- Peptidase Inhibition and Analysis 6
-
- Lung Cancer Treatments and Mutations 11
- Co-authors
- Edurne Arriola (19 shared papers)Álvaro Taus (15 shared papers)Max Hardy-Werbin (12 shared papers)Joan Albanell (8 shared papers)Sergi Clavé (9 shared papers)Marta Salido (8 shared papers)Lara Pijuan (6 shared papers)João de Sousa (1 shared paper)
- Journals
- Journal of Thoracic Oncology (7 papers)Clinical Lung Cancer (4 papers)Clinical Cancer Research (3 papers)OncoImmunology (3 papers)Annals of Oncology (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Pedro Rocha
49 papers receiving 903 citations
Pedro Rocha's Hit Papers
Peers
Comparison fields: 5 of 67
- Oncology 453
- Cancer Research 131
- Pulmonary and Respiratory Medicine 214
- Immunology 79
- Epidemiology 114
Countries citing papers authored by Pedro Rocha
This map shows the geographic impact of Pedro Rocha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Rocha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Rocha more than expected).
Fields of papers citing papers by Pedro Rocha
This network shows the impact of papers produced by Pedro Rocha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Rocha. The network helps show where Pedro Rocha may publish in the future.
Co-authors
The 25 scholars most cited alongside Pedro Rocha, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tarlatamab in Small-Cell Lung Cancer after Platinum-Based Chemotherapy Hit paper breakdown → | 2025 | 90 |
| 2 | Prevalence of atrial fibrillation in the Portuguese population aged 40 and over: the FAMA study. | 2010 | 79 |
| 3 | Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes Hit paper breakdown → | 2024 | 79 |
| 4 | 2017 | 76 | |
| 5 | 2019 | 73 | |
| 6 | 2021 | 53 | |
| 7 | 2018 | 47 | |
| 8 | 2019 | 35 | |
| 9 | 2017 | 29 | |
| 10 | 2014 | 29 | |
| 11 | 2024 | 28 | |
| 12 | 2022 | 27 | |
| 13 | 2024 | 27 | |
| 14 | 2018 | 27 | |
| 15 | 2021 | 22 | |
| 16 | 2014 | 18 | |
| 17 | 2020 | 16 | |
| 18 | 2019 | 14 | |
| 19 | 2022 | 14 | |
| 20 | 2025 | 12 |
About Pedro Rocha
Pedro Rocha is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Epidemiology, Cancer Research and Pathology and Forensic Medicine, having authored 52 papers that have together received 915 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (17 papers), Cancer Immunotherapy and Biomarkers (12 papers), Lung Cancer Treatments and Mutations (11 papers), Neuroendocrine Tumor Research Advances (7 papers), Peptidase Inhibition and Analysis (6 papers), Cancer Genomics and Diagnostics (3 papers), Genetic factors in colorectal cancer (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (453 citations), Cancer Research (131 citations), Pulmonary and Respiratory Medicine (214 citations), Immunology (79 citations) and Epidemiology (114 citations). Pedro Rocha has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Edurne Arriola, Álvaro Taus, Max Hardy-Werbin, Joan Albanell, Sergi Clavé, Marta Salido, Lara Pijuan, João de Sousa, Pedro Adragão and Miguel Mendes. Their work appears in journals such as Journal of Thoracic Oncology, Clinical Lung Cancer, Clinical Cancer Research, OncoImmunology and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.